Lupin intros authorized generic DuexisIbuprofen and famotidine tablets are indicated for the relief of signs and symptoms of rheumatoid arthritis, osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers, the company said, Sandoz enters agreement with Bio-Thera Solutions for Avastin biosimilarBevacizumab is a recombinant humanized monoclonal IgG1 antibody that targets vascular endothelial growth factor, a key mediator of angiogenesis in cancer. AAM makes 2 key appointments The organization is welcoming Polly Webster as vice president of federal affairs and Erik Komendant as senior vice president of government affairs. FDA approves 2 generics from VGYAAN Pharmaceuticals The Food and Drug Administration has approved the company’s generics of Tegretol (carbamazapene tablets) and Lupron (leuprolide acetate injection). FDA approves generic Metrogel Gel from Alembic’s Aleor Dermaceuticals The product had an estimated $29 million U.S. market size for the year ended June 2021, according to data from IQVIA. Sandoz Canada debuts generic Revlimid The company said Canada would be the fifth country in which it is commercializing the product. FDA marks competitive generic therapy approval milestone The agency has approved more than 100 generic drugs with the competitive generic therapy designation since it launched the effort in 2017. Dr. Reddy's intros generic Revlimid in Canada Reddy-Lenalidomide capsules are available in six dosage strengths. Hikma, Bio-Thera Solutions partner on potential Stelara biosimilar Bio-Thera will maintain responsibility for development, manufacturing and supply of the biosimilar Stelara while Hikma will have exclusive rights to commercialize the product in the United States. Camber debuts generic Jadenu Camber's deferasirox tablets are available in 90-, 180- and 360-mg dosage strengths. First Previous 114 115 116 117 118 Next Last
